BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35880594)

  • 61. Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.
    Larbcharoensub N; Mahaprom K; Jiarpinitnun C; Trachu N; Tubthong N; Pattaranutaporn P; Sirachainan E; Ngamphaiboon N
    Am J Clin Oncol; 2018 Dec; 41(12):1204-1210. PubMed ID: 29672367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma.
    Moon JW; Kong SK; Kim BS; Kim HJ; Lim H; Noh K; Kim Y; Choi JW; Lee JH; Kim YS
    Sci Rep; 2017 Dec; 7(1):17810. PubMed ID: 29259270
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
    Moritani S; Sugihara H; Kushima R; Hattori T
    Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
    [TBL] [Abstract][Full Text] [Related]  

  • 64. PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28-8 and E1L3N).
    Ma J; Li J; Qian M; Han W; Tian M; Li Z; Wang Z; He S; Wu K
    Diagn Pathol; 2018 Nov; 13(1):91. PubMed ID: 30463584
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Molecular biological and clinical-morphological studies of gastric tumors associated with Epstein-Barr virus].
    Gurtsevich VE; Novikova EV; Borisova EIu; Stepina VN; Iakovleva LS; Davydov MI; Klimenkov AA; Nered SN; Frank GA; Kozlovskiĭ OM; Britvina VA; Petel'nikova ES; Petrovichev NN; Ruzabakiev RM; Tokunaga M; Zaridze DG
    Vestn Ross Akad Med Nauk; 2000; (3):27-31. PubMed ID: 10765732
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Concordance of immune checkpoints within tumor immune contexture and their prognostic significance in gastric cancer.
    Dai C; Geng R; Wang C; Wong A; Qing M; Hu J; Sun Y; Lo AW; Li J
    Mol Oncol; 2016 Dec; 10(10):1551-1558. PubMed ID: 27720576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PD-1 and PD-L1 gene expressions and their association with Epstein-Barr virus infection in chronic lymphocytic leukemia.
    Gamaleldin MA; Ghallab OM; Nadwan EA; Abo Elwafa RA
    Clin Transl Oncol; 2021 Nov; 23(11):2309-2322. PubMed ID: 34120295
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinicopathological and molecular characteristics of gastric papillary adenocarcinoma.
    Arai T; Komatsu A; Kanazawa N; Nonaka K; Ishiwata T
    Pathol Int; 2023 Aug; 73(8):358-366. PubMed ID: 37341602
    [TBL] [Abstract][Full Text] [Related]  

  • 69. EBV-positive diffuse large B-cell lymphoma features PD-L1 protein but not mRNA overexpression.
    Xue T; Wang WG; Zhou XY; Li XQ
    Pathology; 2018 Dec; 50(7):725-729. PubMed ID: 30389217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Expression comparison and clinical significance of PD-L1 (22C3) and PD-L1 (SP142) in triple negative breast cancer].
    Zhang J; Yuan P; Lei HZ; Liu XY; Li X; Ying JM; Sun GY; Wang SL; Lyu N
    Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):260-267. PubMed ID: 35316876
    [No Abstract]   [Full Text] [Related]  

  • 71. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
    Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
    World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
    Thompson ED; Zahurak M; Murphy A; Cornish T; Cuka N; Abdelfatah E; Yang S; Duncan M; Ahuja N; Taube JM; Anders RA; Kelly RJ
    Gut; 2017 May; 66(5):794-801. PubMed ID: 26801886
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Does Epstein-Barr virus-positive gastric cancer establish a significant relationship with the multiple genes related to gastric carcinogenesis?
    Seo JW; Park KB; Chin HM; Jun KH
    PLoS One; 2023; 18(6):e0283366. PubMed ID: 37285389
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization.
    zur Hausen A; van Grieken NC; Meijer GA; Hermsen MA; Bloemena E; Meuwissen SG; Baak JP; Meijer CJ; Kuipers EJ; van den Brule AJ
    Gastroenterology; 2001 Sep; 121(3):612-8. PubMed ID: 11522745
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virus-associated gastric cancer.
    Pan Y; Lu L; Liu H; Chen D; Han N; Yao R; Wang X; Gao X; Yu J; Chen L; Zhou F; Hao G; Lu Y; Li M; He G; Kang F; Li Z; Tang Y; Zhang J; Wei L; Nie Y
    Front Immunol; 2022; 13():1003859. PubMed ID: 36353623
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Epstein-Barr virus-associated gastric adenocarcinoma].
    Danilova NV; Malkov PG; Oleynikova NA; Mikhailov IA
    Arkh Patol; 2019; 81(3):74-83. PubMed ID: 31317934
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Role of p53, apoptosis, and cell proliferation in early stage Epstein-Barr virus positive and negative gastric carcinomas.
    Ishii HH; Gobe GC; Yoneyama J; Mukaide M; Ebihara Y
    J Clin Pathol; 2004 Dec; 57(12):1306-11. PubMed ID: 15563673
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma.
    Ozturk V; Yikilmaz AS; Kilicarslan A; Bakanay SM; Akinci S; Dilek İ
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e375-e381. PubMed ID: 32295735
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Epstein-Barr Virus and PD-L1 in Esophageal and Esophagogastric Junction Cancer: Differences According to Location and Histological Type.
    Ribeiro MB; Marques SB; Soares IC; Pereira MA; Takeda FR; Safatle-Ribeiro AV; Ribeiro U
    J Gastrointest Surg; 2022 Nov; 26(11):2358-2364. PubMed ID: 35668227
    [No Abstract]   [Full Text] [Related]  

  • 80. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
    Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
    World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.